Hirva Mamdani
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Immunology
- Cancer Research
- Co-authors
- Shadia I. JalalAhmed Bilal KhalidSandro MatosevicGregory A. DurmMelissa L. JohnsonRachel E. SanbornShahid AhmedTony Mok
- Topics
- Lung Cancer Treatments and Mutations (35 papers)Lung Cancer Research Studies (27 papers)Cancer Immunotherapy and Biomarkers (26 papers)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Hirva Mamdani
98 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 597
- Pulmonary and Respiratory Medicine 436
- Molecular Biology 364
- Immunology 143
- Cancer Research 131
Countries citing papers authored by Hirva Mamdani
This map shows the geographic impact of Hirva Mamdani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirva Mamdani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirva Mamdani more than expected).
Fields of papers citing papers by Hirva Mamdani
This network shows the impact of papers produced by Hirva Mamdani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirva Mamdani. The network helps show where Hirva Mamdani may publish in the future.
Co-authorship network of co-authors of Hirva Mamdani
This figure shows the co-authorship network connecting the top 25 collaborators of Hirva Mamdani. A scholar is included among the top collaborators of Hirva Mamdani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirva Mamdani. Hirva Mamdani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 3 | |
| 9 | 4 | |
| 10 | 1 | |
| 11 | 4 | |
| 12 | 1 | |
| 13 | 34 | |
| 14 | 5 | |
| 15 | 2 | |
| 16 | 21 | |
| 17 | 2 | |
| 18 | 45 | |
| 19 | 21 | |
| 20 | 2 |
About Hirva Mamdani
Hirva Mamdani is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 102 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (35 papers), Lung Cancer Research Studies (27 papers) and Cancer Immunotherapy and Biomarkers (26 papers). The work is most often cited by research in Oncology (597 citations), Pulmonary and Respiratory Medicine (436 citations) and Cancer Research (131 citations). Hirva Mamdani has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Shadia I. Jalal, Ahmed Bilal Khalid, Sandro Matosevic, Gregory A. Durm, Melissa L. Johnson, Rachel E. Sanborn, Shahid Ahmed, Tony Mok, Samantha Armstrong and Alexander I. Spira. Their work appears in journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.